Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:I-16-I-20
doi: 10.1161/hc37t1.094545
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carr-White, G. S.
Right arrow Articles by Yacoub, M. H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Carr-White, G. S.
Right arrow Articles by Yacoub, M. H.
Related Collections
Right arrow CT and MRI
Right arrow Echocardiography
Right arrow CV surgery: valvular disease

(Circulation. 2001;104:I-16.)
© 2001 American Heart Association, Inc.


Surgery for Valvular Heart Disease

Incidence, Location, Pathology, and Significance of Pulmonary Homograft Stenosis After the Ross Operation

Gerald S. Carr-White, MRCP; Philip J. Kilner, MD, PhD; Jimmy K.F. Hon, MB, ChB; Thomas Rutledge, MBBS; Sue Edwards, BSc; Elisabeth D. Burman, SRN; Dudley J. Pennell, FRCP; Magdi H. Yacoub, FRS

Departments of Cardiology (G.S.C.-W.), Cardiovascular Magnetic Resonance (P.J.K., E.D.B., D.J.P.), and Academic Surgery (J.K.F.H., T.R., S.E., M.H.Y.), National Heart and Lung Institute, Royal Brompton Hospital, London, UK.

Correspondence to Professor Sir Magdi Yacoub, Professor of Cardiothoracic Surgery, National Heart and Lung Institute, Royal Brompton Hospital, Sydney St, London SW3 6NP, United Kingdom. E-mail g.carr-white{at}virgin.net

Background— The Ross operation has several theoretical advantages. However, concern exists regarding evolving pathology in the pulmonary homograft.

Methods and Results— Consecutive patients (n=144; mean age 31 years, range 2 months to 64 years) undergoing the Ross operation were studied between 1993 and 2000. Echocardiographic examination of the pulmonary homograft was performed immediately after surgery, then at yearly intervals for a mean interval of 48 months. Fifteen patients (mean age 37 years) in whom echocardiography revealed peak pulmonary gradients >=30 mm Hg (mean 46±18 mm Hg) underwent MRI with velocity mapping in a Picker 1.5-T magnet. No patient had more than mild pulmonary regurgitation. Four patients required reoperation for rapidly progressive pulmonary homograft stenosis; in all 4, there was macroscopic and microscopic evidence of a pronounced chronic adventitial reaction, with perivascular infiltration producing extrinsic compression. Freedom from any pulmonary homograft stenosis at 7-year follow-up was 79.7%, with instantaneous hazard falling to zero after 4 years. Freedom from reoperation at 7 years was 96.7%. In those studied with MRI, there was evidence of narrowing of the whole homograft or distal suture line in 14 of 15 patients, with obvious excess surrounding tissue in 11. Mean minimum diameter and peak velocity by MRI were 11±2 mm and 3.2±0.7 m/s, respectively. Multivariate analysis of patient-, surgery-, and homograft-related variables did not reveal any significant risk factors for development of neopulmonary stenosis.

Conclusions— Pulmonary homograft stenosis after the Ross operation is clinically important and appears to represent an early postoperative inflammatory reaction to the pulmonary homograft that leads to extrinsic compression and/or shrinkage.


Key Words: valves • surgery • magnetic resonance imaging • echocardiography